- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06294249
Pain Severity in Flapless Dental Implant Placement Using Laser
March 23, 2024 updated by: Reza Tabrizi, DMD, Shiraz University of Medical Sciences
The Evaluation of Pain Severity in Flapless Dental Implant Placement Using Laser-induced Incisions: A Split Mouth Randomized Clinical Trial Study
The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery.
It was hypothesized that laser did not have any impact on post-op pain.
Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fars
-
Shiraz, Fars, Iran, Islamic Republic of
- Shiraz University of Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult human subjects agreed to participate in the study and return on follow-up times
- Subjects eligible for receiving dental implants
- Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (>5 mm width, and >10 mm height) at the implant sites
- Subjects with sufficient keratinization tissue at the implant sites
Exclusion Criteria:
- Subjects refused to return for follow-up or refused study enrollment.
- Subjects with uncontrolled systemic diseases
- Subjects younger than 18 years
- Subjects receiving psychotropic drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Laser-induced Incision
The Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used.
|
On the treatment side, an incision was made on the crest of the alveolar soft tissue using the laser.
Implant placement was done in both laser and punch arms.
The drilling was performed based on the company (Straumman) protocol.
On each side, a dental implant (Straumman SP, Basel, Switzerland) and healing abutment were placed.
Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
|
Active Comparator: Punch Incision
The soft tissue Osstem punch (South Korea) was used.
|
Implant placement was done in both laser and punch arms.
The drilling was performed based on the company (Straumman) protocol.
On each side, a dental implant (Straumman SP, Basel, Switzerland) and healing abutment were placed.
Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
On the control side, a punch incision was made on the crest of the alveolar soft tissue using using a punch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Severity
Time Frame: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.
|
Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dehiscence
Time Frame: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
The dehiscence was documented in visiting sessions.
The flap dehiscence was diagnosed visually by the clinician.
|
Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
|
Infection
Time Frame: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
The signs and symptoms of infection were documented.
The Infection was diagnosed visually by clinician when the soft tissue redness and pus discharge along with reported pain by the patient is present.
|
Patients were visited at 24, 48, 72 hours, and 7 days after insertion.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: +98-9125850829 Tabrizi, DMD, Shahid Beheshti University of Medical Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
December 1, 2023
Study Completion (Actual)
December 4, 2023
Study Registration Dates
First Submitted
January 22, 2024
First Submitted That Met QC Criteria
February 27, 2024
First Posted (Actual)
March 5, 2024
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
March 23, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20045125
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Jaw, Edentulous, Partially
-
October 6 UniversityNot yet recruitingPartially Edentulous Jaw
-
Institut Straumann AGRecruitingTooth Loss | Dental Implant | Partially Edentulous JawNetherlands, Belgium, Italy, Switzerland
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
University of Alabama at BirminghamZimmer DentalCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompleted
-
NeodentActive, not recruiting
-
University of MichiganTerminatedJaw, Edentulous, PartiallyUnited States
Clinical Trials on Laser-induced Incision
-
University of California, Los AngelesBoston Scientific CorporationTerminatedBenign Biliary Strictures With Current or Prior Biliary ObstructionUnited States
-
Washington University School of MedicineLifeCellCompletedBreast Cancer | Prophylactic Mastectomy | Ductal Carcinoma in Situ - CategoryUnited States
-
Visualase, Inc.UnknownBrain NeoplasmsUnited States
-
Gainesville Eye AssociatesScience in VisionCompletedCataractUnited States
-
Alcon, a Novartis CompanyTerminatedAstigmatism | MyopiaFrance
-
Cairo UniversityRecruitingSecondary Caries Around Resin Composite RestorationsEgypt
-
University of California, IrvineCompleted
-
Urological Research Network, LLCRecruitingMRI | Urinary Incontinence | Prostate Cancer | Ultrasound | Ablation | Sexual Function Disturbances | Prostate Biopsy | Adverse Effects Surgery | Urinary Function DisordersUnited States
-
Cairo UniversityHelwan University; Badr University; Suez UniversityCompleted
-
Fatih Sultan Mehmet Training and Research HospitalCompletedOsteoarthritis, KneeTurkey (Türkiye)